Delivery Order SPE2DB22D3301-SPE2DB25FX8AZ

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CAPLYTA 10.5 MG CAPSULE 30S, a prescription medication. The contract has a firm fixed price, a ceiling value of $26,628.74, and an ultimate completion date of May 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CAPLYTA 42 MG CAPSULE 30S, a prescription medication. The contract is a firm fixed-price delivery order with a ceiling value of $3,497.27 and a completion date of September 12, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000,...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of pharmaceutical product CAPLYTA 42 MG CAPSULE 30S, with a ceiling value of $5,682.82 and a period of performance through August 20, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of CAPLYTA 42 MG CAPSULE 30S. The contract has a total ceiling value of $3,207.14 and is a firm fixed price delivery order, with a completion date of February 19, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,660.15, is for the delivery of CAPLYTA 10.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of July 19, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CAPLYTA 21 MG CAPSULE 30S medication. The contract is a Firm Fixed Price (FFP) arrangement with a ceiling value of $5,940.71 and a period of performance through September 25, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,437.28, is for the delivery of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has a completion date of December 6, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $57,203.16 and an ultimate completion date of October 7, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
The U.S. Defense Logistics Agency (DLA) awarded a $10,153.73 firm-fixed price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the supply of 4,566,078,136 units of the pharmaceutical product CAPLYTA 42 MG CAPSULE 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which provides a wide range of medical commodities to support military treatment programs and...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of CAPLYTA 21 MG capsules. The contract has a ceiling value of $11,801.69 and a performance period through April 3, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor on this award as well as an indefinite delivery contract (IDC) with DLA valued at up to...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX8AZ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of CAPLYTA 10.5 MG CAPSULE 30S. The contract has a ceiling value of $1,365.83 and a period of performance through January 7, 2025. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/7/25, 10:43 AM